News Conference News TCT 2023 Sirolimus- and Paclitaxel-Coated Balloons Well-Matched for In-Stent Restenosis Todd Neale November 02, 2023
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for October 2023 Shelley Wood November 01, 2023
News Conference News TCT 2023 Comparing DCBs in De Novo CAD: Drugs, Design Matter Caitlin E. Cox October 25, 2023
News Conference News TCT 2023 ‘Light at the End of the Tunnel’ for In-Stent Restenosis: AGENT IDE Wins Big Todd Neale October 25, 2023
News Conference News TCT 2023 Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door? L.A. McKeown October 24, 2023
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for July 2023 Shelley Wood July 31, 2023
News Daily News FDA: All Restrictions on Paclitaxel Devices for PAD Are Removed L.A. McKeown July 11, 2023
News Conference News LINC 2023 PROSPECT MONSTER: Real-World Data Confirm Low-Dose DCB Efficacy in PAD L.A. McKeown June 21, 2023
News Conference News LINC 2023 What Works, What’s Noise? Novel Approaches Offer Hope in CLTI L.A. McKeown June 07, 2023
News Industry News Concept Medical’s fourth IDE approval for the MagicTouch Sirolimus Coated Balloon is granted for the treatment of Superficial Femoral Artery Disease (SFA) June 01, 2023
News Daily News Long-term Data Support Paclitaxel-Coated Balloons for In-Stent Restenosis Michael O'Riordan February 24, 2023